The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
Market Analysis and Insights: Global Transmucosal Drug Delivery Systems Market
The global Transmucosal Drug Delivery Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Transmucosal Drug Delivery Systems market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Transmucosal Drug Delivery Systems, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Transmucosal Drug Delivery Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transmucosal Drug Delivery Systems revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Transmucosal Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Transmucosal Drug Delivery Systems revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
Acrux Limited
ALZA Corporation
DURECT Corporation
Generex Biotechnology
Segment by Type
Oral Drug Delivery
Nasal Drug Delivery
Rectal Drug Delivery
Other
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Transmucosal Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transmucosal Drug Delivery Systems companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transmucosal Drug Delivery Systems revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Drug Delivery
1.2.3 Nasal Drug Delivery
1.2.4 Rectal Drug Delivery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Systems Market Perspective (2019-2030)
2.2 Global Transmucosal Drug Delivery Systems Growth Trends by Region
2.2.1 Transmucosal Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transmucosal Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Transmucosal Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Transmucosal Drug Delivery Systems Market Dynamics
2.3.1 Transmucosal Drug Delivery Systems Industry Trends
2.3.2 Transmucosal Drug Delivery Systems Market Drivers
2.3.3 Transmucosal Drug Delivery Systems Market Challenges
2.3.4 Transmucosal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Transmucosal Drug Delivery Systems by Players
3.1.1 Global Transmucosal Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Transmucosal Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Transmucosal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transmucosal Drug Delivery Systems, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Transmucosal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Systems Revenue in 2023
3.5 Global Key Players of Transmucosal Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Transmucosal Drug Delivery Systems, Product and Application
3.7 Global Key Players of Transmucosal Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Transmucosal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Transmucosal Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transmucosal Drug Delivery Systems Market Size (2019-2030)
6.2 North America Transmucosal Drug Delivery Systems Market Size by Type
6.2.1 North America Transmucosal Drug Delivery Systems Market Size by Type (2019-2024)
6.2.2 North America Transmucosal Drug Delivery Systems Market Size by Type (2025-2030)
6.2.3 North America Transmucosal Drug Delivery Systems Market Share by Type (2019-2030)
6.3 North America Transmucosal Drug Delivery Systems Market Size by Application
6.3.1 North America Transmucosal Drug Delivery Systems Market Size by Application (2019-2024)
6.3.2 North America Transmucosal Drug Delivery Systems Market Size by Application (2025-2030)
6.3.3 North America Transmucosal Drug Delivery Systems Market Share by Application (2019-2030)
6.4 North America Transmucosal Drug Delivery Systems Market Size by Country
6.4.1 North America Transmucosal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
6.4.3 North America Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Transmucosal Drug Delivery Systems Market Size by Type
7.2.1 Europe Transmucosal Drug Delivery Systems Market Size by Type (2019-2024)
7.2.2 Europe Transmucosal Drug Delivery Systems Market Size by Type (2025-2030)
7.2.3 Europe Transmucosal Drug Delivery Systems Market Share by Type (2019-2030)
7.3 Europe Transmucosal Drug Delivery Systems Market Size by Application
7.3.1 Europe Transmucosal Drug Delivery Systems Market Size by Application (2019-2024)
7.3.2 Europe Transmucosal Drug Delivery Systems Market Size by Application (2025-2030)
7.3.3 Europe Transmucosal Drug Delivery Systems Market Share by Application (2019-2030)
7.4 Europe Transmucosal Drug Delivery Systems Market Size by Country
7.4.1 Europe Transmucosal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
7.4.3 Europe Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Transmucosal Drug Delivery Systems Market Size (2019-2030)
8.2 China Transmucosal Drug Delivery Systems Market Size by Type
8.2.1 China Transmucosal Drug Delivery Systems Market Size by Type (2019-2024)
8.2.2 China Transmucosal Drug Delivery Systems Market Size by Type (2025-2030)
8.2.3 China Transmucosal Drug Delivery Systems Market Share by Type (2019-2030)
8.3 China Transmucosal Drug Delivery Systems Market Size by Application
8.3.1 China Transmucosal Drug Delivery Systems Market Size by Application (2019-2024)
8.3.2 China Transmucosal Drug Delivery Systems Market Size by Application (2025-2030)
8.3.3 China Transmucosal Drug Delivery Systems Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Transmucosal Drug Delivery Systems Market Size (2019-2030)
9.2 Asia Transmucosal Drug Delivery Systems Market Size by Type
9.2.1 Asia Transmucosal Drug Delivery Systems Market Size by Type (2019-2024)
9.2.2 Asia Transmucosal Drug Delivery Systems Market Size by Type (2025-2030)
9.2.3 Asia Transmucosal Drug Delivery Systems Market Share by Type (2019-2030)
9.3 Asia Transmucosal Drug Delivery Systems Market Size by Application
9.3.1 Asia Transmucosal Drug Delivery Systems Market Size by Application (2019-2024)
9.3.2 Asia Transmucosal Drug Delivery Systems Market Size by Application (2025-2030)
9.3.3 Asia Transmucosal Drug Delivery Systems Market Share by Application (2019-2030)
9.4 Asia Transmucosal Drug Delivery Systems Market Size by Region
9.4.1 Asia Transmucosal Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Transmucosal Drug Delivery Systems Market Size by Region (2019-2024)
9.4.3 Asia Transmucosal Drug Delivery Systems Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Transmucosal Drug Delivery Systems Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Transmucosal Drug Delivery Systems Introduction
11.1.4 3M Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.1.5 3M Recent Developments
11.2 Antares Pharma
11.2.1 Antares Pharma Company Details
11.2.2 Antares Pharma Business Overview
11.2.3 Antares Pharma Transmucosal Drug Delivery Systems Introduction
11.2.4 Antares Pharma Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.2.5 Antares Pharma Recent Developments
11.3 Aveva Drug Delivery Systems
11.3.1 Aveva Drug Delivery Systems Company Details
11.3.2 Aveva Drug Delivery Systems Business Overview
11.3.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Systems Introduction
11.3.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.3.5 Aveva Drug Delivery Systems Recent Developments
11.4 Corium International
11.4.1 Corium International Company Details
11.4.2 Corium International Business Overview
11.4.3 Corium International Transmucosal Drug Delivery Systems Introduction
11.4.4 Corium International Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.4.5 Corium International Recent Developments
11.5 Acrux Limited
11.5.1 Acrux Limited Company Details
11.5.2 Acrux Limited Business Overview
11.5.3 Acrux Limited Transmucosal Drug Delivery Systems Introduction
11.5.4 Acrux Limited Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.5.5 Acrux Limited Recent Developments
11.6 ALZA Corporation
11.6.1 ALZA Corporation Company Details
11.6.2 ALZA Corporation Business Overview
11.6.3 ALZA Corporation Transmucosal Drug Delivery Systems Introduction
11.6.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.6.5 ALZA Corporation Recent Developments
11.7 DURECT Corporation
11.7.1 DURECT Corporation Company Details
11.7.2 DURECT Corporation Business Overview
11.7.3 DURECT Corporation Transmucosal Drug Delivery Systems Introduction
11.7.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.7.5 DURECT Corporation Recent Developments
11.8 Generex Biotechnology
11.8.1 Generex Biotechnology Company Details
11.8.2 Generex Biotechnology Business Overview
11.8.3 Generex Biotechnology Transmucosal Drug Delivery Systems Introduction
11.8.4 Generex Biotechnology Revenue in Transmucosal Drug Delivery Systems Business (2019-2024)
11.8.5 Generex Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
Acrux Limited
ALZA Corporation
DURECT Corporation
Generex Biotechnology
听
听
*If Applicable.
